相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Abnormal promoter DNA methylation in juvenile myelomonocytic leukemia is not caused by mutation in DNMT3A
Marcin W. Wlodarski et al.
BLOOD (2011)
Advances in the prognostication and management of advanced MDS in children
Henrik Hasle et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
The Spliceosome as an Indicted Conspirator in Myeloid Malignancies
Omar Abdel-Wahab et al.
CANCER CELL (2011)
Immunosuppressive Therapy for Patients With Myelodysplastic Syndrome: A Prospective Randomized Multicenter Phase III Trial Comparing Antithymocyte Globulin Plus Cyclosporine With Best Supportive Care-SAKK 33/99
Jakob R. Passweg et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Prevalence and prognostic value of IDH1 and IDH2 mutations in childhood AML: a study of the AML-BFM and DCOG study groups
F. Damm et al.
LEUKEMIA (2011)
Frequent pathway mutations of splicing machinery in myelodysplasia
Kenichi Yoshida et al.
NATURE (2011)
Somatic SF3B1 Mutation in Myelodysplasia with Ring Sideroblasts
E. Papaemmanuil et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Mutations of an E3 ubiquitin ligase c-Cbl but not TET2 mutations are pathogenic in juvenile myelomonocytic leukemia
Hideki Muramatsu et al.
BLOOD (2010)
Oral iron chelators: Prospects for future development
John Porter
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
James W. Vardiman et al.
BLOOD (2009)
KITD816V+ systemic mastocytosis associated with KITD816V+ acute erythroid leukaemia: first case report with molecular evidence for same progenitor cell derivation
S. A. McClintock-Treep et al.
JOURNAL OF CLINICAL PATHOLOGY (2009)
Chemotherapy and dasatinib induce long-term hematologic and molecular remission in systemic mastocytosis with acute myeloid leukemia with KITD816V
Celalettin Ustun et al.
LEUKEMIA RESEARCH (2009)
Pathologic clonal cytotoxic T-cell responses: nonrandom nature of the T-cell-receptor restriction in large granular lymphocyte leukemia
MW Wlodarski et al.
BLOOD (2005)
A prospective, randomised, phase II study of horse antithymocyte globulin vs rabbit antithymocyte globulin as immune-modulating therapy in patients with low-risk myelodysplastic syndromes
M Stadler et al.
LEUKEMIA (2004)
A pediatric approach to the WHO classification of myelodysplastic and myeloproliferative diseases
H Hasle et al.
LEUKEMIA (2003)
分享论文
